V Bala Subramanian
Bugworks Research India Pvt Ltd CCAMP
Bala is a microbiologist and a drug hunter who received his PhD from the University of Wisconsin-Madison and post-doctoral training at the Albert Einstein College of Medicine, NY. Subsequently he gained leadership and management experience over two decades in the pharmaceutical industry. Among various roles, Bala has been a Project Leader, a Principal Investigator, a Department Head, & Executive Director at AstraZeneca India, and most recently co-Founder and head of R&D, Bugworks Research Inc. Bala’s technical experience is rich with 25+ years in Infection research and 20+ years in anti-bacterial drug discovery. Bala has led projects from basic biology through to early clinical development; pioneered the PK/PD science for anti-TB drugs; co-discovered the target for the anti-TB drug, Isoniazid; co-discovered AZD5847 & TBA-7371, novel drug candidates for the treatment of tuberculosis; co-discovered MMV253, a novel drug candidate for the treatment of malaria.
Besides possessing extensive drug discovery experience, Bala is articulate with strong people skills and brings rich experience in working with cross-disciplinary and trans-national teams, establishing and sustaining collaborations as well as public-private partnerships. He has been a Principal Investigator in several prestigious research grants from CARB-X, Wellcome Trust, NIAID, BMGF, EUFW7, and BIRAC - India. Bala has a strong publication track record with over 40 peer-reviewed publications in International high-impact journals such as Science, Nature, PNAS (USA) etc. He has chaired International conferences such as the Gordon Research Conference on TB Drug Development.